Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$467.38
-$10.52 (-2.2%)
Real Time Data Delayed 15 Min.
VRTX Articles
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Albermarle, Allergan, Boston Scientific, eBay, FedEx, Gogo, LendingTree, Nokia, UPS and Vertex Pharmaceuticals.
Published:
Last Updated:
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
Published:
Last Updated:
Merrill Lynch believes that this could be the year biotechs break out. The firm has a few picks, bad and good, that it believes will play a big role in the coming year.
Published:
Last Updated:
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
Published:
Last Updated:
It is no secret that biotech stocks can bring great rewards for investors. They can also deliver serious pain. Fortunately, most of these are currently projected to deliver a solid 2018.
Published:
Last Updated:
While these eight stocks are not being touted as Credit Suisse's formal top picks for 2018, the timeline sure sets them up to be among the top contenders.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
Published:
Last Updated:
Wednesday was a relatively positive day for the U.S. broad markets with green arrows across the board with a few exceptions. Crude oil was up again, but this time Oil & Gas stocks responded very...
Published:
Last Updated:
Shares of Vertex Pharmaceuticals shot up after the company announced dramatic results from its early and mid-stage trials in cystic fibrosis. The stock pushed to an all-time high on the back of these...
Published:
Last Updated:
Stocks were indicated to open only slightly higher on Wednesday after a mixed bag of corporate earnings. What investors need to understand is that the major equity indexes remain just under all-time...
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Tuesday include Agilent, Apple, Citigroup, Exxon, M&T Bank, Snap, Toyota and Twitter.
Published:
Last Updated:
Many on Wall Street feel that some of the more speculative institutional tech money may be rotating into the biotechs, and with good reason.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include AK Steel, Altice USA, Biogen, Caterpillar, Gilead Sciences and Oracle.
Published:
Last Updated:
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
Published:
Last Updated: